These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37460781)

  • 1. Association Between Migraine and Ischemic Cardio-Cerebrovascular Disease (CCVD) and Effects of Triptans and Ergotamine on the Risk of Ischemic CCVD in Patients with Migraine in the Korean NHIS-HEALS Cohort.
    Kim Y; Shin SJ; Lee JW; Kim YS; You HS; Kim J; Kang HT
    Clin Drug Investig; 2023 Jul; 43(7):541-550. PubMed ID: 37460781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between triglyceride-glucose index, cardio-cerebrovascular diseases, and death in Korean adults: A retrospective study based on the NHIS-HEALS cohort.
    Kim J; Shin SJ; Kang HT
    PLoS One; 2021; 16(11):e0259212. PubMed ID: 34735502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: systematic review of observational studies.
    Roberto G; Raschi E; Piccinni C; Conti V; Vignatelli L; D'Alessandro R; De Ponti F; Poluzzi E
    Cephalalgia; 2015 Feb; 35(2):118-31. PubMed ID: 25246519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of ischemic complications related to the intensity of triptan and ergotamine use.
    Wammes-van der Heijden EA; Rahimtoola H; Leufkens HG; Tijssen CC; Egberts AC
    Neurology; 2006 Oct; 67(7):1128-34. PubMed ID: 17030745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher Pulse Pressure Is Associated With Increased Risk of Cardio-cerebrovascular Disease and All-Cause Mortality: A Korean National Cohort Study.
    Lee JW; Shin SJ; Kim J; Kang HT
    Am J Hypertens; 2022 Jul; 35(7):647-655. PubMed ID: 35363861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Channeling Bias in the Evaluation of Cardiovascular Risk: The Importance of Comparator Selection in Observational Research.
    Li H; Mawanda F; Mitchell L; Zhang X; Goodloe R; Vincent M; Motsko S
    Pharmaceut Med; 2022 Aug; 36(4):247-259. PubMed ID: 35788962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Stroke in Migraineurs Using Triptans. Associations with Age, Sex, Stroke Severity and Subtype.
    Albieri V; Olsen TS; Andersen KK
    EBioMedicine; 2016 Apr; 6():199-205. PubMed ID: 27211561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Acute Myocardial Infarction, Heart Failure, and Death in Migraine Patients Treated with Triptans.
    Ghanshani S; Chen C; Lin B; Duan L; Shen YA; Lee MS
    Headache; 2020 Nov; 60(10):2166-2175. PubMed ID: 33017476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying the factors underlying discontinuation of triptans.
    Wells RE; Markowitz SY; Baron EP; Hentz JG; Kalidas K; Mathew PG; Halker R; Dodick DW; Schwedt TJ
    Headache; 2014 Feb; 54(2):278-89. PubMed ID: 24001117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute migraine treatment with oral triptans and NSAIDs in a managed care population.
    Ng-Mak DS; Hu XH; Chen YT; Ma L
    Headache; 2008 Sep; 48(8):1176-85. PubMed ID: 18819177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke and cardiovascular risk factors among working-aged Finnish migraineurs.
    Sumelahti ML; Sumanen MS; Mattila KJ; Sillanmäki L; Sumanen M
    BMC Public Health; 2021 Jun; 21(1):1088. PubMed ID: 34098909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice.
    Hall GC; Brown MM; Mo J; MacRae KD
    Neurology; 2004 Feb; 62(4):563-8. PubMed ID: 14981171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical implications of the migraine cardio- and cerebrovascular association: unmet needs of patients.
    Diener HC; Kurth T; Holle D
    Cephalalgia; 2015 Feb; 35(2):140-5. PubMed ID: 25324501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of rizatriptan and sumatriptan versus Cafergot in the acute treatment of migraine.
    Zhang L; Hay JW
    CNS Drugs; 2005; 19(7):635-42. PubMed ID: 15984898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access to Triptans for Acute Episodic Migraine: A Qualitative Study.
    Khan S; Mascarenhas A; Moore JE; Knowles S; Gomes T
    Headache; 2015; 55 Suppl 4():199-211. PubMed ID: 26178420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Migraine, triptans, and the risk of developing rosacea: a population-based study within the United Kingdom.
    Spoendlin J; Voegel JJ; Jick SS; Meier CR
    J Am Acad Dermatol; 2013 Sep; 69(3):399-406. PubMed ID: 23643255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ergotamine Use and Overuse in Taiwan: A Retrospective Cohort Study.
    Chen CL; Yeh YC; Chen YY
    Headache; 2018 Mar; 58(3):416-423. PubMed ID: 29168165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Stroke and Myocardial Infarction Among Initiators of Triptans.
    Petersen CL; Hougaard A; Gaist D; Hallas J
    JAMA Neurol; 2024 Mar; 81(3):248-254. PubMed ID: 38315477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A higher probability of subsequent stroke and ischemic heart disease in migraine patients: a longitudinal follow-up study in Korea.
    Kwon MJ; Choi HG; Kim YH; Kim JH; Rim HT; Lee HS; Oh JK; Chang IB; Song JH; Kim JH
    J Headache Pain; 2023 Jul; 24(1):98. PubMed ID: 37525107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute treatment of migraine.
    Tepper SJ; Spears RC
    Neurol Clin; 2009 May; 27(2):417-27. PubMed ID: 19289223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.